
样式: 排序: IF: - GO 导出 标记为已读
-
Management of Depression in Medical Patients: The Role of Clinical Evaluation. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-10-20 Giovanni A Fava,Jenny Guidi
-
Symptom Change during Waitlist for Medicated and Nonmedicated Patients with Chronic Depression. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-09-14 Andreas Høstmælingen,Helene Amundsen Nissen-Lie,Bruce Wampold,Pål G Ulvenes
INTRODUCTION Patients seeking psychotherapy often spend time on waitlist (WL), the effect of which is largely unknown. WL patients may forego alternative non-psychotherapeutic assistance and thus do more poorly than had they not been placed on a WL. The course of symptoms might also be influenced by use of antidepressant medication (ADM), an issue that remains unexplored in the literature. OBJECTIVE
-
The Time Has Come to Include It in DSM Iterations. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-09-05 Thomas N Wise
-
Allostatic Load in Children and Adolescents: A Systematic Review. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-09-04 Marcella Lucente,Jenny Guidi
INTRODUCTION The concept of allostatic load encompasses the cumulative effects of both ordinary daily life events as well as major challenges, and also includes related health-damaging behavior. Allostatic overload ensues when environmental challenges exceed the individual's ability to cope. Identification of allostatic load is carried out through the use of biomarkers and clinimetric criteria. Studies
-
Depression and Anxiety Trajectories in Chronic Disease: A Systematic Review and Meta-Analysis. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-08-22 Amelia J Scott,Ashleigh B Correa,Madelyne A Bisby,Blake F Dear
INTRODUCTION People living with chronic diseases are at an increased risk of anxiety and depression, which are associated with poorer medical and psychosocial outcomes. Many studies have examined the trajectories of depression and anxiety in people with specific diseases, including the predictors of these trajectories. This is valuable for understanding the process of adjustment to diseases and informing
-
The Ghent Psychotherapy Study: A Pragmatic, Stratified, Randomized Parallel Trial into the Differential Efficacy of Psychodynamic and Cognitive-Behavioral Interventions in Dependent and Self-Critical Depressive Patients. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-08-10 Reitske Meganck,Mattias Desmet,Kimberly Van Nieuwenhove,Melissa De Smet,Vicky Hennissen,Femke Truijens,Rosa De Geest,Goedele Hermans,Claudi Bockting,Ufuoma Angelica Norman,Tom Loeys,Ruth Inslegers,Tim Van den Abeele,Chris Baeken,Stijn Vanheule
INTRODUCTION Different types of psychotherapy are effective for treating major depressive disorder across groups yet show large within-group differences. Patient personality style is considered a potentially useful variable for treatment matching. OBJECTIVE This study is the first experimental test of the interaction between therapeutic approach and patients' dependent versus self-critical personality
-
Brief Psychotherapeutic Intervention Compared with Treatment as Usual for Adolescents with Nonsuicidal Self-Injury: Outcomes over a 2-4-Year Follow-Up. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-07-24 Franziska Rockstroh,Alexandra Edinger,Johannes Josi,Gloria Fischer-Waldschmidt,Romuald Brunner,Franz Resch,Michael Kaess
INTRODUCTION The "Cutting Down Programme" (CDP), a brief psychotherapeutic intervention for treating nonsuicidal self-injury (NSSI) in adolescents, was comparable to high-quality treatment as usual (TAU) in a previous randomized controlled trial (RCT). OBJECTIVE The aim of the study was to evaluate the long-term outcomes of the CDP over up to 4 years. METHODS Assessments of NSSI, suicide attempts,
-
Illness Denial in Medical Disorders: A Systematic Review. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-07-10 Chiara Patierno,Giovanni A Fava,Danilo Carrozzino
INTRODUCTION Illness denial pertains to medical patients who do not acknowledge the presence or severity of their disease or the need of treatment. OBJECTIVE This systematic review was performed to clarify the clinical role and manifestations of illness denial, its impact on health attitudes and behavior, as well as on short- and long-term outcomes in patients with medical disorders. METHODS The systematic
-
Behavioural Activation versus Treatment as Usual for Depressed Older Adults in Primary Care: A Pragmatic Cluster-Randomised Controlled Trial. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-06-29 Noortje P Janssen,Peter Lucassen,Marcus J H Huibers,David Ekers,Theo Broekman,Judith E Bosmans,Harm Van Marwijk,Jan Spijker,Richard Oude Voshaar,Gert-Jan Hendriks
INTRODUCTION Effective non-pharmacological treatment options for depression in older adults are lacking. OBJECTIVE The effectiveness of behavioural activation (BA) by mental health nurses (MHNs) for depressed older adults in primary care compared with treatment as usual (TAU) was evaluated. METHODS In this multicentre cluster-randomised controlled trial, 59 primary care centres (PCCs) were randomised
-
Virtual Reality Exposure to a Healthy Weight Body Is a Promising Adjunct Treatment for Anorexia Nervosa. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-05-30 Simone C Behrens,Joachim Tesch,Philine J B Sun,Sebastian Starke,Michael J Black,Hannah Schneider,Jacopo Pruccoli,Stephan Zipfel,Katrin E Giel
INTRODUCTION/OBJECTIVE Treatment results of anorexia nervosa (AN) are modest, with fear of weight gain being a strong predictor of treatment outcome and relapse. Here, we present a virtual reality (VR) setup for exposure to healthy weight and evaluate its potential as an adjunct treatment for AN. METHODS In two studies, we investigate VR experience and clinical effects of VR exposure to higher weight
-
The World Federation for Psychotherapy (WFP) 23rd World Congress of Psychotherapy. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-05-25
-
The Importance of Symptom Reduction for Functional Improvement after Cognitive Behavioral Therapy for Anxiety and Depression: A Causal Mediation Analysis. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-05-24 Otto R F Smith,Leif E Aarø,Marit Knapstad
INTRODUCTION The temporal relationship between symptoms and functioning in the context of cognitive behavioral therapy (CBT) for anxiety and depression is not fully understood, and there are few high-quality studies that have examined to what extent late intervention effects of CBT on functioning are mediated by initial intervention effects on symptoms while accounting for the initial effects on functioning
-
Discontinuation of Antidepressant Medications: A Significant Healthcare Problem Insufficiently Addressed by the NICE Guidelines. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-05-24 Fiammetta Cosci,Virginie-Anne Chouinard,Guy Chouinard
-
Psychotherapy for Chronic In- and Outpatients with Common Mental Disorders: The “Choose Change” Effectiveness Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2023-04-06 Andrew T. Gloster, Elisa Haller, Jeanette Villanueva, Victoria Block, Charles Benoy, Andrea H. Meyer, Sandra Brogli, Veronika Kuhweide, Maria Karekla, Klaus Bader, Marc Walter, Undine Lang
Introduction: Treatment non-response occurs regularly, but psychotherapy is seldom examined for such patients. Existing studies targeted single diagnoses, were relatively small, and paid little attention to treatment under real-world conditions. Objective: The Choose Change trial tested whether psychotherapy was effective in treating chronic patients with treatment non-response in a transdiagnostic
-
Effectiveness of Psychotherapy on Prevention of Suicidal Re-Attempts in Psychiatric Emergencies: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials Psychother. Psychosom. (IF 22.8) Pub Date : 2023-04-04 Hyunsuk Jeong, Hyeon Woo Yim, Seung-Yup Lee, Marc N. Potenza, Na-Jin Kim
Introduction: Many psychological interventions aim to prevent suicide, but there is limited information regarding their comparative effectiveness. Objectives: We conducted a systematic review and network meta-analysis to evaluate the relative effects of psychological interventions for preventing suicide re-attempts in psychiatric emergencies. Methods: We searched PubMed, Embase, Cochrane, and PsycINFO
-
Cognitive Behavioral Therapy for Late-Life Depression (CBTlate): Results of a Multicenter, Randomized, Observer-Blinded, Controlled Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2023-03-31 Forugh S. Dafsari, Bettina Bewernick, Sabine Böhringer, Katharina Domschke, Moritz Elsaesser, Margrit Löbner, Melanie Luppa, Lukas Preis, Julia Püsken, Sandra Schmitt, Andreea-Johanna Szekely, Martin Hellmich, Wiebke Müller, Michael Wagner, Oliver Peters, Lutz Frölich, Steffi Riedel-Heller, Elisabeth Schramm, Martin Hautzinger, Frank Jessen
Introduction: Different psychotherapeutic interventions for late-life depression (LLD) have been proposed, but their evaluation in large, multicenter trials is rare. Objective: The present study evaluated the efficacy of a specific cognitive behavioral therapy (CBT) for LLD (LLD-CBT) in comparison with a supportive unspecific intervention (SUI), both administered in a specialist psychiatric outpatient
-
Patients as Health Producers: The Psychosomatic Foundation of Lifestyle Medicine Psychother. Psychosom. (IF 22.8) Pub Date : 2023-03-23 Giovanni A. Fava
N/A Psychother Psychosom
-
Evaluating a Comprehensive Model of Euthymia Psychother. Psychosom. (IF 22.8) Pub Date : 2023-03-14
Introduction: In research and treatment of mood disorders, “euthymia” traditionally denotes the absence of clinically significant mood disturbance. A newer, expanded definition of euthymia also includes positive affect and psychological well-being. Objective: We aimed to test this comprehensive model of euthymia and estimate the coherence and predictive power of each factor in the model. Methods: Community-dwelling
-
Evaluating a Comprehensive Model of Euthymia. Psychother. Psychosom. (IF 22.8) Pub Date : 2023-03-14 Jeffrey R Vittengl,Robin B Jarrett,Eunyoe Ro,Lee Anna Clark
INTRODUCTION In research and treatment of mood disorders, "euthymia" traditionally denotes the absence of clinically significant mood disturbance. A newer, expanded definition of euthymia also includes positive affect and psychological well-being. OBJECTIVE We aimed to test this comprehensive model of euthymia and estimate the coherence and predictive power of each factor in the model. METHODS Community-dwelling
-
Maternal Benzodiazepines and Z-Drugs Use during Pregnancy and Adverse Birth and Neurodevelopmental Outcomes in Offspring: A Population-Based Cohort Study Psychother. Psychosom. (IF 22.8) Pub Date : 2023-03-10 Adrienne Y.L. Chan, Le Gao, Louise M. Howard, Emily Simonoff, Dave Coghill, Patrick Ip, Wallis C.Y. Lau, Katja Taxis, Ian C.K. Wong, Kenneth K.C. Man
Introduction: The use of benzodiazepines and/or z-drugs in women of childbearing age has increased. Objective: The aim of the study was to evaluate whether gestational benzodiazepine and/or z-drug exposure is associated with adverse birth and neurodevelopmental outcomes. Methods: A population-based cohort including mother-child pairs from 2001 to 2018 in Hong Kong was analysed to compare gestationally
-
Inhibitory Control Training Enhanced by Transcranial Direct Current Stimulation to Reduce Binge Eating Episodes: Findings from the Randomized Phase II ACCElect Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2023-03-08 Katrin E. Giel, Kathrin Schag, Sebastian M. Max, Peter Martus, Stephan Zipfel, Andreas J. Fallgatter, Christian Plewnia
Introduction: Binge eating disorder (BED) is characterized by recurrent binge eating (BE) episodes with loss of control. Inhibitory control impairments, including alterations in dorsolateral prefrontal cortex (dlPFC) functioning, have been described for BED. A targeted modulation of inhibitory control circuits by the combination of inhibitory control training and transcranial brain stimulation could
-
More Treatment, but Not Less Anxiety and Mood Disorders: Why? Seven Hypotheses and Their Evaluation Psychother. Psychosom. (IF 22.8) Pub Date : 2023-02-06 Johan Ormel, Paul M.G. Emmelkamp
Psychother Psychosom
-
-
Real-Time fMRI Functional Connectivity Neurofeedback Reducing Repetitive Negative Thinking in Depression: A Double-Blind, Randomized, Sham-Controlled Proof-of-Concept Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2023-01-11 Aki Tsuchiyagaito, Masaya Misaki, Namik Kirlic, Xiaoqian Yu, Stella M. Sánchez, Gabe Cochran, Jennifer L. Stewart, Ryan Smith, Kate D. Fitzgerald, Michael L. Rohan, Martin P. Paulus, Salvador M. Guinjoan
Introduction: Repetitive negative thinking (RNT) is a cognitive process focusing on self-relevant and negative experiences, leading to a poor prognosis of major depressive disorder (MDD). We previously identified that connectivity between the precuneus/posterior cingulate cortex (PCC) and right temporoparietal junction (rTPJ) was positively correlated with levels of RNT. Objective: In this double-blind
-
Introductory Course on Well-Being Therapy Psychother. Psychosom. (IF 22.8) Pub Date : 2023-01-09 Jenny Guidi, Fiammetta Cosci, Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell, Gregor Hasler, Jenneke E. Wiersma, Massimo Biondi, Richard Balon, Per Bech, Tom
Psychother Psychosom
-
The Journal’s Task Psychother. Psychosom. (IF 22.8) Pub Date : 2023-01-06 Jenny Guidi, Fiammetta Cosci
Psychother Psychosom
-
Keeping Politics out of Doctors’ Offices: A Reply to Fogelson Psychother. Psychosom. (IF 22.8) Pub Date : 2023-01-04 Steven L. Dubovsky
Psychother Psychosom
-
Implementing the Biopsychosocial Model in Clinical Medicine: A Tribute to Giovanni Fava Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-23 Stephan Zipfel, Bernd Löwe, Katrin Giel, Hans-Christoph Friederich, Peter Henningsen
Psychother Psychosom
-
Guidelines Circulated for the Prescription of Benzodiazepines Are Out of Synch with Clinical Practice and Evidence-Based Reviews Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-22 David Fogelson
Psychother Psychosom
-
Effects up to 20-Year Follow-Up of Preventive Cognitive Therapy in Adults Remitted from Recurrent Depression: The DELTA Study Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-22 Amanda M. Legemaat, Huibert Burger, Gert J. Geurtsen, Marlies Brouwer, Philip Spinhoven, Damiaan Denys, Claudi L. Bockting
Introduction: Major depressive disorder (MDD) is common, and recurrence rates are high. Preventive Cognitive Therapy (PCT), has been shown to prolong time to recurrence and reduce risk of recurrence(s) over 2–10 years in patients with recurrent depression. Objective: The aim of the study was to examine the effectiveness of PCT over 20 years on time to first recurrence, cumulative proportion of first
-
What Kind of Patients Receive Inpatient and Day-Hospital Treatment in Departments of Psychosomatic Medicine and Psychotherapy in Germany? Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-14 Stephan Doering, Stephan Herpertz, Tobias Hofmann, Matthias Rose, Katrin Imbierowicz, Franziska Geiser, Ilona Croy, Kerstin Weidner, Jörg Rademacher, Silke Michalek, Eva Morawa, Yesim Erim, Per Teigelack, Martin Teufel, Armin Hartmann, Claas Lahmann, Eva Milena Johanne Peters, Johannes Kruse, Dirk von Boetticher, Christoph Herrmann-Lingen, Mariel Nöhre, Martina de Zwaan, Ulrike Dinger, Hans-Christoph
Introduction: Germany is one of the few countries with a medical specialty of psychosomatic medicine and psychotherapy and many treatment resources of this kind. Objective: This observational study describes the psychosomatic treatment programs as well as a large sample of day-hospital and inpatients in great detail using structured diagnostic interviews. Methods: Mental disorders were diagnosed according
-
Increasing Obstacles to Benzodiazepine Prescribing due to the Misguided Actions of Regulatory Agencies: A Response to Fogelson Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-14 Richard Balon
Psychother Psychosom
-
The Effectiveness of Metacognitive Therapy Compared to Behavioral Activation for Severely Depressed Outpatients: A Single-Center Randomized Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-13 Anja Schaich, Janne Outzen, Nele Assmann, Carlotta Gebauer, Kamila Jauch-Chara, Daniel Alvarez-Fischer, Michael Hüppe, Adrian Wells, Ulrich Schweiger, Jan Philipp Klein, Eva Fassbinder
Introduction: Major depressive disorder (MDD) is a highly prevalent and disabling disorder. This study examines two psychotherapy methods for MDD, behavioral activation (BA), and metacognitive therapy (MCT), when applied as outpatient treatments to severely affected patients. Methods: The study was conducted in a tertiary outpatient treatment center. Patients with a primary diagnosis of MDD (N = 122)
-
Psychological Interventions for Adult Post-Traumatic Stress Disorder Are Effective Irrespective of Concurrent Psychotropic Medication Intake: A Meta-Analysis of Randomized Controlled Trials Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-09 Thole H. Hoppen, Nexhmedin Morina
Background: Participants are allowed to stay on their prescribed psychotropic medication in most trials examining psychological interventions for adult post-traumatic stress disorder (PTSD). Objectives: We aimed to conduct the first meta-analysis investigating the potential influence of such concurrent medication on efficacy. Method: To this end, we searched Medline, PsycINFO, Web of Science, and PTSDpubs
-
Giovanni Fava’s Contributions to the Conceptualization and Evidence Base of Clinimetrics Psychother. Psychosom. (IF 22.8) Pub Date : 2022-12-07 Tom Sensky
Psychother Psychosom
-
The Quest for a Valid Model of Long-Term Treatment of Depression: Sequential Model and Giovanni A. Fava. Psychother. Psychosom. (IF 22.8) Pub Date : 2022-11-17 Richard Balon
-
Contents Vol. 91, 2022 Psychother. Psychosom. (IF 22.8) Pub Date : 2022-11-16
Psychother Psychosom 2022;91:I–VI
-
Clinimetric Integration of Diagnostic Criteria for a Personalized Psychiatry Psychother. Psychosom. (IF 22.8) Pub Date : 2022-11-08 Giovanni A. Fava
Psychother Psychosom
-
Ultra-Processed Food Addiction: An Epidemic? Psychother. Psychosom. (IF 22.8) Pub Date : 2022-11-07 Erica M. LaFata, Ashley N. Gearhardt
Psychother Psychosom
-
Longitudinal Development of Symptoms and Staging in Psychiatry and Clinical Psychology: A Tribute to Giovanni Fava Psychother. Psychosom. (IF 22.8) Pub Date : 2022-11-07 Ulrich Schnyder
Psychother Psychosom
-
Operational Definitions of Treatment Response and Remission in Obsessive-Compulsive Disorder Capture Meaningful Improvements in Everyday Life Psychother. Psychosom. (IF 22.8) Pub Date : 2022-10-28 David Mataix-Cols, Erik Andersson, Kristina Aspvall, Julia Boberg, James J. Crowley, Elles de Schipper, Lorena Fernández de la Cruz, Oskar Flygare, Ekaterina Ivanova, Fabian Lenhard, Lina Lundström, Christian Rück, Eva Serlachius, Matti Cervin
Introduction: The operational definitions of treatment response, partial response, and remission in obsessive-compulsive disorder (OCD) are widely used in clinical trials and regular practice. However, the clinimetric sensitivity of these definitions, that is, whether they identify patients that experience meaningful changes in their everyday life, remains unexplored. Objective: The objective was to
-
Application and Innovation of Biopsychosocial Model Psychother. Psychosom. (IF 22.8) Pub Date : 2022-09-30 George Nasra
Psychother Psychosom 2022;91:3–40
-
-
Farewell to Prof. Giovanni A. Fava after 30 Years and Welcome to the New Editors Psychother. Psychosom. (IF 22.8) Pub Date : 2022-07-05
Psychother Psychosom
-
The Effectiveness of 6 versus 12 Months of Dialectical Behavior Therapy for Borderline Personality Disorder: A Noninferiority Randomized Clinical Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2022-06-23 Shelley F. McMain, Alexander L. Chapman, Janice R. Kuo, Katherine L. Dixon-Gordon, Timothy Henry Guimond, Cathy Labrish, Wanrudee Isaranuwatchai, David L. Streiner
Introduction: Evidence-based psychotherapies for borderline personality disorder (BPD) are lengthy, posing a barrier to their access. Brief psychotherapy may achieve comparable outcomes to long-term psychotherapy for BPD. Evidence is needed regarding the comparative effectiveness of short- versus long-term psychotherapy for BPD. Objective: The aim was to determine if 6 months of Dialectical Behavior
-
An Editor’s Journey Ends, but the Journal’s Mission Continues Psychother. Psychosom. (IF 22.8) Pub Date : 2022-06-20 Giovanni A. Fava
Psychother Psychosom
-
Who’s Afraid of Benzodiazepines? Psychother. Psychosom. (IF 22.8) Pub Date : 2022-06-09 Richard Balon
Psychother Psychosom
-
Stigmatization of Benzodiazepines: Pharmacologic and Nonpharmacologic Contributions Psychother. Psychosom. (IF 22.8) Pub Date : 2022-06-09 Edward K. Silberman
Psychother Psychosom
-
Benzodiazepines Are Efficacious and Safe for Long-Term Use: Clinical Research Data and More than Sixty Years in the Market Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-31 Antonio E. Nardi, Laiana A. Quagliato
Psychother Psychosom
-
Efficacy of App-Based Cognitive Behavioral Therapy for Body Dysmorphic Disorder with Coach Support: Initial Randomized Controlled Clinical Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-19 Sabine Wilhelm, Hilary Weingarden, Jennifer L. Greenberg, Susanne S. Hoeppner, Ivar Snorrason, Emily E. Bernstein, Thomas H. McCoy, Oliver T. Harrison
Introduction: Body dysmorphic disorder (BDD) is severe, chronic, and undertreated. Apps could substantially improve treatment access. Objective: We provide an initial test of the usability and efficacy of coach-supported app-based cognitive behavioral therapy (CBT) for BDD. The Perspectives app covers core treatment components: psychoeducation, cognitive restructuring, exposure with response prevention
-
Evaluation of Inference-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder: A Multicenter Randomized Controlled Trial with Three Treatment Modalities Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-18
Introduction: Inference-based cognitive-behavioral therapy (I-CBT) is a specialized psychological treatment for obsessive-compulsive disorder (OCD) without deliberate and prolonged exposure and response prevention (ERP) that focuses on strengthening reality-based reasoning and correcting the dysfunctional reasoning giving rise to erroneous obsessional doubts and ideas. Objective: The present study
-
IFP News Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-17 G.A. Fava, International Federation for Psychotherapy (IFP), International College of Psychosomatic Medicine (ICPM), Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell
Psychother Psychosom
-
Representation of Benzodiazepines in Treatment Guidelines: The Paradox of Undesirable Objectivity Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-12 Vladan Starcevic
Psychother Psychosom
-
Infrequent Intranasal Oxytocin Followed by Positive Social Interaction Improves Symptoms in Autistic Children: A Pilot Randomized Clinical Trial Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-11 Jiao Le, Lan Zhang, Weihua Zhao, Siyu Zhu, Chunmei Lan, Juan Kou, Qianqian Zhang, Yingying Zhang, Qin Li, Zhuo Chen, Meina Fu, Christian Montag, Rong Zhang, Wenxu Yang, Benjamin Becker, Keith M. Kendrick
Introduction: There are currently no approved drug interventions for social behavior dysfunction in autism spectrum disorder (ASD). Previous trials investigating effects of daily intranasal oxytocin treatment have reported inconsistent results and have not combined it with positive social interaction. However, in two preclinical studies we established that treatment every other day rather than daily
-
Diabetes Distress and Depression during COVID-19: Response to Breznoscakova et al. Uncovering the Untold Emotional Toll of Living with Diabetes in the COVID-19 Era Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-06 Andreas Schmitt, Bernhard Kulzer, Dominic Ehrmann, Thomas Haak, Norbert Hermanns
Psychother Psychosom
-
Erratum Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-05 G.A. Fava, International Federation for Psychotherapy (IFP), International College of Psychosomatic Medicine (ICPM), Giovanni A. Fava, Elena Tomba, Fiammetta Cosci, Carmen Berrocal Montiel, Fortunato Pesarin, Ulrich Schnyder, Antonio Barbosa, Jesse H. Wright, Jan Scott, Michael Bagby, Eva-Lotta Brakemeier, Jenny Guidi, Fava Maurizio, Piero Porcelli, James I. Hudson, N. Marks, Isaac Marks, Toeres Theorell
Psychother Psychosom
-
Benzodiazepines Remain Important Therapeutic Options in Psychiatric Practice Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-03 Steven L. Dubovsky, Dori Marshall
Benzodiazepines and medications acting on benzodiazepine receptors that do not have a benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory bodies as having limited benefit and significant risks. Data presented in this article support the use of these medications as treatments of choice for acute situational anxiety, chronic anxiety disorders, insomnia, alcohol withdrawal
-
Chronic Loneliness: Neurocognitive Mechanisms and Interventions Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-02
Psychother Psychosom
-
Chronic Loneliness: Neurocognitive Mechanisms and Interventions. Psychother. Psychosom. (IF 22.8) Pub Date : 2022-05-02 Mitjan Morr,Xiqin Liu,Rene Hurlemann,Benjamin Becker,Dirk Scheele
-
The Clinical Science of Euthymia: A Conceptual Map Psychother. Psychosom. (IF 22.8) Pub Date : 2022-04-14 Jenny Guidi, Giovanni A. Fava
Euthymia is a trans-diagnostic construct characterized by lack of mood disturbances; presence of positive affect; balance of psychological well-being dimensions, flexibility, consistency, and resistance to stress. The aim of this critical review is to draw a conceptual map of euthymia. Relationships with other constructs, continuum between euthymia and dysthymia with discomfort as an intermediate area